Recent Finacing
Recent Raise
Elanix Biotechnologies AG develops and commercializes progenitor cell–based tissue regeneration products for wound, dermatological, and gynecological applications, operates GMP cell banks, and offers OTC, TEP, and CaaS business units.
Focus Areas
Total Raised
Funding round